Genmab A/S(Nasdaq: GMAB) andIncyte(Nasdaq: INCY) today announced a clinical trial collaboration to evaluate petosemtamab, ...
New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...
New Survival Data in HER2-Positive Gastroesophageal Adenocarcinoma at ESMO 2026 - Jazz Pharmaceuticals / cancer, esmo 2026, ...
Pope Leo XIV’s doctors said final tests show the lung adenocarcinoma removed earlier this month was localized and that no ...
Completion of light dose-escalation Part A of Phase 1 study identifies regimen for further evaluation in Part B, supporting ...
Fintel on MSN
Tango Therapeutics, Inc. announces Phase 1/2 vopimetostat trial results and 14% workforce reduction
Tango Therapeutics, Inc. announced updated results from its ongoing Phase 1/2 clinical trial evaluating vopimetostat in combination with RAS(ON) inhibitors from Revolution Medicines, Inc. As of the ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis ...
Daraxonrasib Versus Chemotherapy in Metastatic Pancreatic Cancer – Additional Subgroup Analyses / cancer, cancer care, Cancer ...
In October 2026, the Vatican announced that Pope Leo XIV had undergone a right lower lobectomy to remove a lung nodule that ...
UCSF expert Trever Bivona explains lung adenocarcinoma, including symptoms, survival rates, genetic testing and advances in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results